This is the exact reason why they do phase 2 and 3 studies. Just because preclinical data is promising, doesn't mean it will work out
This is the exact reason why they do phase 2 and 3 studies. Just...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
51.5¢ |
Change
0.055(12.0%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 52.0¢ | 40.0¢ | $1.809M | 3.939M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13639 | 50.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 103012 | 7 |
View Market Depth
| Last trade - 10.59am 26/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
